ClinConnect ClinConnect Logo
Search / Trial NCT04080492

A Cardiac Disease Quality of Life Study

Launched by THE CLEVELAND CLINIC · Sep 4, 2019

Trial Information

Current as of June 16, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "A Cardiac Disease Quality of Life Study," is looking at how certain heart conditions affect the quality of life for patients. Specifically, it focuses on adults who have hypertrophic obstructive cardiomyopathy (a condition where the heart muscle is abnormally thick), thoracic aortic dilatation (widening of the aorta in the chest), or heart disease caused by radiation therapy. The study aims to gather information about these patients' experiences and challenges, especially since many of them cannot undergo surgery to treat their conditions.

To participate, individuals must be between 18 and 70 years old and have a confirmed diagnosis of one of the conditions mentioned. They should also be receiving care at the Cleveland Clinic and have access to a phone, computer, or tablet with internet to complete follow-up questionnaires. Participants can expect to share their experiences through these questionnaires over time, helping researchers understand how these heart conditions impact daily life. It’s important to note that those who have had or will have surgery for their heart condition in the next nine months cannot join the study.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18-70 at time of consent with a confirmed diagnosis of HCM, TAD, and/or RIHD being seen at CC Main Campus for a comprehensive clinical cardiac evaluation (i.e. physician, surgeon, nurse practitioner, geneticist, testing, imaging, etc) to define treatment plan for either diagnosis as per Cleveland Clinic provider.
  • Patient or an individual in their social support network has the equipment (phone, computer, tablet) and internet connection to complete the emailed follow-up questionnaires.
  • Exclusion Criteria:
  • Previously had surgery or plans to have surgery (full/mini sternotomy or endovascular) in the next nine months for HCM or TAD.
  • Inability or unwillingness to comply with study requirements in the opinion of the investigator.
  • Inability to provide informed consent.

About The Cleveland Clinic

The Cleveland Clinic is a renowned nonprofit academic medical center based in Cleveland, Ohio, recognized for its commitment to advancing healthcare through innovative research and clinical excellence. As a leading sponsor of clinical trials, the Cleveland Clinic leverages its multidisciplinary expertise and state-of-the-art facilities to conduct groundbreaking studies aimed at improving patient outcomes across a wide range of medical conditions. With a strong emphasis on patient-centered care, the institution fosters collaboration among researchers, clinicians, and patients to explore new treatments and therapies, contributing significantly to the global body of medical knowledge.

Locations

Cleveland, Ohio, United States

Cleveland, Ohio, United States

Patients applied

0 patients applied

Trial Officials

Milind Desai, M. D.

Principal Investigator

The Cleveland Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials